Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Baiyunshan Pharmaceutical General Factory is a major pharmaceutical manufacturing entity based in China and a core subsidiary of the publicly traded Guangzhou Baiyunshan Pharmaceutical Holdings. Established in 1973, it has grown into one of the country's largest production bases for antibiotics and synthetic drugs. The company gained significant market prominence with the launch of Jinge, the first domestic generic version of sildenafil citrate, which has become a leading product in the Chinese erectile dysfunction market. Its extensive product portfolio includes a variety of cephalosporins, penicillins, and other essential medicines in both oral and injectable forms. The factory operates multiple GMP-certified production lines and is heavily involved in the research and development of generic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Baiyunshan Pharmaceutical General Factory.